Main
>
ONCOLOGY (**)
>
Kidney Cancer>RCC>MET ***
>
Treatment
>
DE. M. AveluMAb(1)+Axitinib(2)
>
(*) USA Approval Date: 2019. 05.15.
(*) USA Approval Date: 2019. 05.15.'s products
This section has no products